←
Codagenix512 posts
Codagenix avatar

Codagenix

@Codagenix

Design Platform for Vaccine & Oncolytic Virus development. Vaccines: COVID, Flu, RSV, Dengue. Oncology: Breast Cancer and Solid Tumors

◷ Joined July 2013▧ 91 Photos and videos
Codagenix avatar
Codagenix@Codagenix·28 Mar 2024

Dr. Jeffrey Fu, CBO, Codagenix, describes what is needed in next-generation COVID vaccines. Our vaccine program strives address these factors as a live-attenuated, intranasal vaccine that induces an antibody and cell-mediated immunity (CMI). Learn more: codagenix.com

Post attachment
Codagenix avatar
Codagenix@Codagenix·21 Mar 2024

Did you know? RSV poses a significant risk to children; more than half of RSV deaths occur in children ages 6 months and older. Learn more about our work to develop an RSV vaccine for children: codagenix.com

Post attachment
Codagenix avatar
Codagenix@Codagenix·11 Feb 2024

Today, on International Day of Women and Girls in Science, we shine a spotlight on the incredible #womeninscience who push the boundaries of science and healthcare, including our very own Director of Preclinical Operations, Keri Wyllie, MPA. Learn more: unesco.org/en/days/women-gir…

0:11
Codagenix avatar
Codagenix@Codagenix·25 Jan 2024

Curious to learn about the biggest takeaways from #JPM24? Check out this article from @BioSpace that includes updates from Codagenix and many more. Read here: biospace.com/article/jpm-202… #biopharma #biotech #innovation #healthcare

Codagenix avatar
Codagenix@Codagenix·10 Jan 2024

This #JPM24, Codagenix’s CEO Paul Grint had the opportunity to speak with Tyler Patchen of @BioSpace about Codagenix’s live attenuated virus approach to #vaccine development. Read the full article: biospace.com/article/jpm-202…

Codagenix avatar
Codagenix@Codagenix·7 Dec 2023

Dr. Johanna Kaufmann, EVP Oncology and Immunology, will be participating in a panel at the 8th Annual Oncolytic Virotherapy Summit on December 14 at noon ET. We hope to see you there! Learn more: ter.li/41bxld

Post attachment